Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  Pharming  /  Wat krijgt Pharming voor Ruconest van Salix..??

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel Pharming Group AEX:PHARM.NL, NL0010391025

  • 0,875 10 mei 2024 09:35
  • +0,002 (+0,23%) Dagrange 0,869 - 0,877
  • 1.037.773 Gem. (3M) 6,8M

Wat krijgt Pharming voor Ruconest van Salix..??

83 Posts
Pagina: «« 1 2 3 4 5 | Laatste | Omlaag ↓
  1. forum rang 10 DeZwarteRidder 20 maart 2015 11:49
    ARTICLE 2
    SOURCES OF SUPPLY AND SUPPLY RELATIONSHIP

    2.1 Commercial Supply of Finished Product. During the Term, Pharming shall Manufacture (or shall cause to be Manufactured), in accordance with the provisions of this Agreement, the Specifications, cGMP and Applicable Laws, all quantities of the Finished Product ordered by Santarus, its Affiliates or Sublicensees pursuant to this Agreement in connection with Commercialization activities of Santarus, its Affiliates and its Sublicensees (the “Commercial Finished Product”). Santarus shall pay Pharming the Supply Price in accordance with the terms of the License Agreement for such Commercial Finished Product, which shall be the sole consideration payable for the Commercial Finished Product and all associated Manufacturing activities hereunder
  2. forum rang 10 DeZwarteRidder 20 maart 2015 11:50
    ARTICLE 3
    SUPPLY OF FINISHED PRODUCT

    3.1 Forecasts; Orders.
    (a) Forecasts. The Parties shall establish a process to ensure that written, non-binding, rolling [***] ([***]) month forecasts, by month, of estimated requirements for Finished Product in the Territory (“Forecast(s)”) will be provided by Santarus to Pharming and will be approved on at least a [***] basis by the Steering Committee at the meetings as specified in Section 2.3 of the License Agreement or more frequently if reasonably requested by either Party; such process shall include a mechanism by which (i) Pharming shall communicate to Santarus its Manufacturing and distribution forecasts on a global basis in advance of a Steering Committee meeting (with the necessary lead time to be mutually agreed); (ii) the first Forecast (the “Initial Forecast”) is approved by the Steering Committee on or before [***] of the License Agreement; and (iii) the Forecast shall be updated and revised on a not less than [***] basis. Pharming shall use the Forecast for planning purposes and make available (or cause to be made available) the capacity required to Manufacture the forecasted quantities of Finished Product within the time frames specified in each Forecast.
    (b) Orders. Santarus shall submit to Pharming written orders consistent with the applicable Forecast (each, an “Order”) for the delivery of Finished Product at least [***] ([***]) calendar days prior to the specified delivery date. Each Order will be approved by the Manufacturing Relationship Team. Each Order shall specify the quantity or, if more than one shipment is requested, quantities of Finished Product ordered by SKU, the requested delivery date or dates, the delivery address(es) and any applicable shipping information. Pharming shall Manufacture (or shall cause to be Manufactured) the Finished Product in the quantities and by the delivery dates set forth in the applicable Orders. In the event of a shortage of capacity at any Existing Manufacturing Facility, the Parties shall ensure that Santarus receives at least [***] (based upon the then applicable worldwide forecasts) with respect to available capacity.

    3.2 Safety Stock. During the Term, Pharming shall maintain a safety stock equal to at least [***] ([***]) months demand of each of the Skimmed Milk, Drug Substance, Drug Product and Finished Product based on the then current Forecast (or such other equivalent amounts of Skimmed Milk, Drug Substance, Drug Product and Finished Product that together provide for approximately [***] ([***]) months of Finished Product inventory), excluding in each case Commercial Finished Product held by Santarus [***] (the “Safety Stock”). For clarity, the Santarus Safety Stock shall be allocated separately from safety stock Pharming is required to hold for other Persons. Pharming shall inform Santarus from time to time, upon Santarus’ reasonable request, concerning the inventory levels of Safety Stock, and Pharming shall manage the Safety Stock as part of its overall inventory on a First Expiry/First Out basis.

    3.3 Supply Commitment. Pharming shall supply to Santarus amounts of Finished Product ordered by Santarus on any Order made in accordance with the terms of this Agreement, and Pharming further agrees to use Commercially Reasonable Efforts to supply (to the extent ordered by Santarus) quantities in excess of these amounts.
  3. Sursum 20 maart 2015 12:01
    quote:

    DeZwarteRidder schreef op 20 maart 2015 11:49:

    ARTICLE 2
    SOURCES OF SUPPLY AND SUPPLY RELATIONSHIP

    2.1 Commercial Supply of Finished Product. During the Term, Pharming shall Manufacture (or shall cause to be Manufactured), in accordance with the provisions of this Agreement, the Specifications, cGMP and Applicable Laws, all quantities of the Finished Product ordered by Santarus, its Affiliates or Sublicensees pursuant to this Agreement in connection with Commercialization activities of Santarus, its Affiliates and its Sublicensees (the “Commercial Finished Product”). Santarus shall pay Pharming the Supply Price in accordance with the terms of the License Agreement for such Commercial Finished Product, which shall be the sole consideration payable for the Commercial Finished Product and all associated Manufacturing activities hereunder
    "Santarus shall pay Pharming the Supply Price in accordance with the terms of the License Agreement for such Commercial Finished Product, which shall be the sole consideration payable for the Commercial Finished Product and all associated Manufacturing activities hereunder"

    Dit komt dus volledig overeen met het jaarverslag. Ik lees hier nog steeds niets over betalingen aan pharming vanwege gratis verstrekte monsters.
83 Posts
Pagina: «« 1 2 3 4 5 | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium

Markt lijkt groeipotentieel Pharming te onderschatten

Het laatste advies leest u als abonnee van IEX Premium

Inloggen Word Abonnee

Pharming Nieuws

  1. 09:40 RBC verlaagt koersdoel Pharming
  2. 08 mei Update: Flinke omzetstijging Pharming 2
  3. 08 mei AEX houdt 900 punten waarschijnlijk niet vast, zorgen Ahold, Pharming en SBM voor spektakel? 2
  4. 19 apr Pharming lost voor 123 miljoen euro aan obligaties af
  5. 18 apr Pharming rondt plaatsing obligaties af 5
  6. 18 apr Pharming vervangt converteerbare lening 6
  7. 08 apr Pharming rondt rekrutering voor klinische studie leniolisib met kinderen af
  8. 14 mrt CEO: Pharming haalt omzet uit steeds meer landen 2
  9. 14 mrt Lichte plus voor AEX voorzien; zullen Pharming en Basic-Fit de boel opschudden?
  10. 14 mrt Pharming rekent ook voor 2024 op dubbelcijferige omzetgroei 2

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!